Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CDT Equity Inc. - Common Stock
(NQ:
CDT
)
1.500
-0.230 (-13.29%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CDT Equity Inc. - Common Stock
< Previous
1
2
Next >
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
May 07, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
May 06, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
April 16, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
April 07, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
March 26, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Inc. Announces Reverse Stock Split
March 25, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
March 18, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
March 12, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
March 05, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Positions for Transformational Growth
March 04, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
February 24, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
February 20, 2026
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
January 02, 2026
Engagement reinforces CDT’s strategy to unlock value from its solid-form asset portfolio
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Increases Bitcoin Holding
October 17, 2025
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Inc. Announces Reverse Stock Split
October 09, 2025
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Executes Cryptocurrency Treasury Reserve Strategy
September 17, 2025
Initial digital asset acquisition marks milestone in capital diversification initiative
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
September 03, 2025
Cryptocurrency treasury reserve strategy is designed to diversify capital structure while reinforcing CDT's innovation-led model
From
CDT Equity Inc.
Via
GlobeNewswire
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
August 26, 2025
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial data
From
CDT Equity Inc.
Via
GlobeNewswire
Conduit to Change Name to CDT Equity Inc.
August 05, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
July 08, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
July 07, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
June 04, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
May 22, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
May 21, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
May 16, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
May 09, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
May 08, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Announces Leadership Changes
April 16, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
April 11, 2025
From
Conduit Pharmaceuticals
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
